top of page

Liverra

Typical dosing: 1/4 capsule/day

The liver peptides in Liverra are based on the original Khavinson bioregulator known as Svetinorm (also called A-7 or Peptide Complex A-7). These are short-chain, low-molecular-weight peptides (typically up to ~10,000 Daltons, often di-, tri-, or tetrapeptides) extracted from the liver tissue of young, healthy animals (usually calves under 12 months old). The key principle is tissue-specific action: these peptides are designed to target liver cells (hepatocytes) preferentially, helping to address age- or stress-related peptide deficiencies that impair normal function.

 

Mechanism of Action

 

Khavinson's research shows that these peptides work at the cellular and molecular level by:

​

  • Entering cells and interacting directly with DNA (often in promoter regions), influencing gene expression.

  • Normalizing protein synthesis in liver cells.

  • Promoting hepatocyte regeneration and repair of damaged tissue.

  • Regulating metabolic processes, including those involved in detoxification pathways.

  • Reducing oxidative stress and supporting overall cellular homeostasis.

 

Unlike many supplements that act superficially, these bioregulators are said to restore the liver's "memory" of optimal function by correcting epigenetic-like changes from aging, toxins, infections, or overload. They cross barriers (including gut and potentially blood-brain) and act intracellularly without needing injections.

​

Key Claimed Benefits (From Clinical Observations and Studies)

​

Clinical studies (primarily from the St. Petersburg Institute of Bioregulation and Gerontology, led by Prof. Khavinson) and user reports highlight:
 

  • Enhanced detoxification: Improves the liver's ability to process and eliminate toxins, metabolic byproducts, hormones, and environmental burdens, which can reduce systemic load and support energy/vitality.

  • Hepatoprotective effects: Stabilizes liver enzymes (e.g., lowered ALT/AST in studies), reduces bilirubin, and protects against damage from factors like alcohol, medications, chemotherapy, radiation, or chronic conditions (e.g., hepatitis).

  • Metabolic support: Aids in nutrient breakdown (fats, carbs, proteins), bile production, and glucose regulation, potentially helping with fatigue, weight management, and digestive issues.

  • Reduced symptoms: Many report less fatigue, better appetite, improved working capacity, and relief from dyspepsia (indigestion) or sluggish digestion.

  • Regeneration and anti-aging: Supports cell proliferation, tissue repair, and may contribute to broader longevity effects seen in Khavinson's work (e.g., telomere support, reduced tumor risk in animal models).

 

In one reported clinical trial on patients with chronic hepatitis or post-chemo/radiation, Svetinorm led to objective improvements in biochemical markers and subjective well-being.

​

Relevance to Gut Balancing and Autism Support

​

In the context of autism (where many experience gut dysbiosis, leaky gut, impaired detox, and oxidative stress), optimized liver function is foundational. The liver handles phase I/II detoxification, processes gut-derived toxins (e.g., from dysbiotic bacteria or undigested food), and supports bile flow for fat digestion and toxin excretion back into the gut. By strengthening liver capacity:

​

  • It may help clear metabolites or irritants that could otherwise contribute to neuroinflammation via the gut-brain axis.

  • Better toxin handling reduces burden during gut protocols (e.g., when killing pathogens or introducing probiotics, which can release die-off toxins).

  • Improved metabolism and reduced oxidative stress align with common ASD biomedical focuses (e.g., glutathione support, methylation). 

​

While direct studies on Svetinorm/liver peptides for autism are lacking (most Khavinson research focuses on aging, organ repair, and general health), the detox and metabolic support make it a logical adjunct in protocols addressing underlying physiology.

 

These are dietary supplements (not drugs in most Western contexts), with evidence mainly from Russian studies and anecdotal reports. Results vary, and they're not a standalone treatment. Consult a healthcare provider experienced in functional/biomedical approaches to ASD for personalized use.

bottom of page